Farhad Jadidi-Niaragh

35PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Dec 17, 2025
Nanotechnology-based PD-L1 siRNA codelivery systems for improving cancer immunotherapy.

Naghmeh Jabarimani, Mohammad Saleh Sadeghi, Maryam Edalat

|Jul 15, 2025
The Safety and Efficacy of Anti-LAG-3 for Patients with Melanoma: A Systematic Review and Meta-analysis Study.

Negar Nejati, Behrouz Robat-Jazi, Kianmehr Saleh

|Jul 11, 2025
Boosting breast cancer immunotherapy through targeted siRNA delivery and sequential chemotherapy.

Naghmeh Jabarimani, Ehsan Khabazian, Bahar Morshedi

|Jan 02, 2025
Simultaneous blockade of the CD73/EGFR axis inhibits tumor growth.

Keivan Ardeshiri, Hadi Hassannia, Ghasem Ghalamfarsa

|Dec 13, 2024
The emerging role of TIM-3 in colorectal cancer: a promising target for immunotherapy.

Reza Karami, Mehrdad Fathi, Pooya Jalali

|Sep 21, 2024
Combined cancer immunotherapy based on targeting adenosine pathway and PD-1/PDL-1 axis.

Mehrdad Fathi, Asieh Zarei, Ata Moghimi

Pageof 6

Frequent Collaborators

5 joint publications

Mehdi Yousefi

4 joint publications

Hamed Mohammadi

4 joint publications

Bahman Yousefi

4 joint publications

Leili Aghebati-Maleki